APGE
Price
$58.24
Change
+$1.94 (+3.45%)
Updated
Nov 5, 04:52 PM (EDT)
6 days until earnings call
SRRK
Price
$28.63
Change
+$0.96 (+3.47%)
Updated
Nov 5, 04:00 PM (EDT)
6 days until earnings call
Ad is loading...

APGE vs SRRK

Header iconAPGE vs SRRK Comparison
Open Charts APGE vs SRRKBanner chart's image
Apogee Therapeutics
Price$58.24
Change+$1.94 (+3.45%)
Volume$345
CapitalizationN/A
Scholar Rock Holding
Price$28.63
Change+$0.96 (+3.47%)
Volume$73.55K
CapitalizationN/A
View a ticker or compare two or three
APGE vs SRRK Comparison Chart
Loading...
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
VS
APGE vs. SRRK commentary
Nov 06, 2024

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is APGE is a Buy and SRRK is a Buy.

COMPARISON
Comparison
Nov 06, 2024
Stock price -- (APGE: $56.30 vs. SRRK: $27.67)
Brand notoriety: APGE and SRRK are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: APGE: 71% vs. SRRK: 38%
Market capitalization -- APGE: $3.19B vs. SRRK: $2.5B
APGE [@Biotechnology] is valued at $3.19B. SRRK’s [@Biotechnology] market capitalization is $2.5B. The market cap for tickers in the [@Biotechnology] industry ranges from $498.83B to $0. The average market capitalization across the [@Biotechnology] industry is $2.82B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

APGE’s FA Score shows that 0 FA rating(s) are green whileSRRK’s FA Score has 0 green FA rating(s).

  • APGE’s FA Score: 0 green, 5 red.
  • SRRK’s FA Score: 0 green, 5 red.
According to our system of comparison, APGE is a better buy in the long-term than SRRK.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

APGE’s TA Score shows that 6 TA indicator(s) are bullish while SRRK’s TA Score has 5 bullish TA indicator(s).

  • APGE’s TA Score: 6 bullish, 2 bearish.
  • SRRK’s TA Score: 5 bullish, 5 bearish.
According to our system of comparison, APGE is a better buy in the short-term than SRRK.

Price Growth

APGE (@Biotechnology) experienced а +2.53% price change this week, while SRRK (@Biotechnology) price change was -9.07% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +4.22%. For the same industry, the average monthly price growth was +14.28%, and the average quarterly price growth was +9.89%.

Reported Earning Dates

APGE is expected to report earnings on Nov 11, 2024.

SRRK is expected to report earnings on Mar 11, 2025.

Industries' Descriptions

@Biotechnology (+4.22% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
APGE($3.19B) has a higher market cap than SRRK($2.5B). APGE YTD gains are higher at: 101.503 vs. SRRK (47.181). APGE has higher annual earnings (EBITDA): -134.74M vs. SRRK (-207.14M). APGE has more cash in the bank: 676M vs. SRRK (190M). APGE has less debt than SRRK: APGE (4.08M) vs SRRK (68M). APGE (0) and SRRK (0) have equivalent revenues.
APGESRRKAPGE / SRRK
Capitalization3.19B2.5B128%
EBITDA-134.74M-207.14M65%
Gain YTD101.50347.181215%
P/E RatioN/AN/A-
Revenue00-
Total Cash676M190M356%
Total Debt4.08M68M6%
FUNDAMENTALS RATINGS
SRRK: Fundamental Ratings
SRRK
OUTLOOK RATING
1..100
21
VALUATION
overvalued / fair valued / undervalued
1..100
78
Overvalued
PROFIT vs RISK RATING
1..100
69
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
34
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
95

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
APGESRRK
RSI
ODDS (%)
N/A
Bearish Trend 2 days ago
87%
Stochastic
ODDS (%)
Bullish Trend 2 days ago
83%
Bullish Trend 2 days ago
89%
Momentum
ODDS (%)
Bullish Trend 2 days ago
73%
Bearish Trend 2 days ago
88%
MACD
ODDS (%)
Bullish Trend 2 days ago
80%
Bearish Trend 2 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
86%
Bearish Trend 2 days ago
87%
TrendMonth
ODDS (%)
Bearish Trend 2 days ago
82%
Bullish Trend 2 days ago
85%
Advances
ODDS (%)
Bullish Trend 2 days ago
85%
Bullish Trend 8 days ago
86%
Declines
ODDS (%)
Bearish Trend 6 days ago
71%
Bearish Trend 2 days ago
90%
BollingerBands
ODDS (%)
Bullish Trend 2 days ago
90%
Bearish Trend 2 days ago
85%
Aroon
ODDS (%)
Bearish Trend 2 days ago
89%
N/A
View a ticker or compare two or three
Ad is loading...
APGE
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
SRRK
Daily Signalchanged days ago
Gain/Loss if shorted
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RERGX58.240.13
+0.22%
American Funds Europacific Growth R6
MSECX13.680.01
+0.07%
Morgan Stanley Inst International Eq C
IHOAX18.80N/A
N/A
Hartford International Opportunities A
VGSAX36.00N/A
N/A
Virtus Duff & Phelps Glb Rl Estt Secs A
BOSCX19.44-0.06
-0.31%
BNY Mellon Sm Cp Val C

APGE and

Correlation & Price change

A.I.dvisor indicates that over the last year, APGE has been loosely correlated with SYRE. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if APGE jumps, then SYRE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To APGE
1D Price
Change %
APGE100%
+3.32%
SYRE - APGE
39%
Loosely correlated
+3.27%
BHVN - APGE
38%
Loosely correlated
-1.65%
ALLO - APGE
38%
Loosely correlated
+10.29%
ACLX - APGE
37%
Loosely correlated
+0.31%
SRRK - APGE
34%
Loosely correlated
-2.64%
More

SRRK and

Correlation & Price change

A.I.dvisor indicates that over the last year, SRRK has been loosely correlated with ORMP. These tickers have moved in lockstep 42% of the time. This A.I.-generated data suggests there is some statistical probability that if SRRK jumps, then ORMP could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To SRRK
1D Price
Change %
SRRK100%
-2.64%
ORMP - SRRK
42%
Loosely correlated
+2.80%
PLRX - SRRK
41%
Loosely correlated
-0.14%
VTGN - SRRK
40%
Loosely correlated
+3.54%
ONCY - SRRK
40%
Loosely correlated
-3.39%
SNDX - SRRK
39%
Loosely correlated
-0.21%
More